News Coverage
|
Press Releases
06/23/09 Acucela’s Novel Visual Cycle Modulator Demonstrates Promise as a Treatment for Dry Age-Related Macular Degeneration
05/18/09 Acucela founder to present at BIO Business Forum
05/12/09 Acucela Presents Dry AMD Therapy Data at ARVO
04/28/09 Acucela Higlights Data to be Presented at ARVO
04/07/09 Acucela Founder to Speak at C21 BioVentures Conference
03/30/09 Acucela Hires Head of Clinical Development and Regulatory Affairs
02/19/09 Acucela Founder to Speak at Ophthalmology Conference
11/07/08 Acucela to Present at the Rodman & Renshaw Healthcare Conference
10/28/08 Acucela to Present at the 2008 BIO Investor Forum
09/04/08 Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry AMD
09/04/08 Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for Rebamipide for Dry Eye
06/12/08 Acucela to Present at BIO International Convention
06/03/08 Acucela Doses First Subject in Phase I Trial for Age-Related Macular Degeneration
05/20/08 Acucela to Present at C21 Bioventures Conference
05/07/08 Acucela Files Investigational New Drug Application
-- Orally-available Small Molecule for Dry Form of AMD
04/29/08 Acucela Presents Preclinical Data from Retinopathy Study Demonstrating Improvement in Retinal Abnormalities
04/22/08 Acucela Announces Presentation of Data in Preclinical Study of Retinopathy
03/18/08 Acucela to Present at INVEST NORTHWEST 2008 Conference